🔎 Trials Near Me

Home › Diffuse Large B-Cell Lymphoma › Ohio › Columbus

Diffuse Large B-Cell Lymphoma clinical trials in Columbus, OH

10 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

RecruitingPhase 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06649812

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

RecruitingPhase 1
  • The Ohio State University (OSU), Columbus
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07226843

Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

RecruitingPhase 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06536049

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

RecruitingPhase 1/2
  • The Ohio State University Wexner Medical Center, Columbus
Ages 13 to 90 · All sexes · Updated Aug 6, 2026 · NCT06533579

A Long-term Extension Study of PCI-32765 (Ibrutinib)

RecruitingPhase 3
  • The Ohio State University- James Cancer Hospital, Columbus
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT01804686

DALY II USA/ MB-CART2019.1 for DLBCL

RecruitingPhase 2
  • The Ohio State University Wexner Medical Center James Cancer, Columbus
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

RecruitingPhase 1
  • The Ohio state University, Columbus
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05077527

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

RecruitingPhase 1
  • Ohio State University, Columbus
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT04775745

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

RecruitingPhase 1
  • The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Ages 18 and older · All sexes · Updated Oct 2, 2025 · NCT05780034

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

RecruitingPhase 1/2
  • The Ohio State University Comprehensive Cancer Center, Columbus
Ages 18 and older · All sexes · Updated Aug 4, 2022 · NCT04502394

Diffuse Large B-Cell Lymphoma trials in other cities

Other studies in Columbus

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.